
- Pharmaceutical Technology-03-02-2011
- Volume 35
- Issue 3
Is Facebook the Place for FDA?
Social media tools have taken over many aspects of our lives, now including regulatory info.
If you haven't seen it yet, FDA has a Facebook page. In fact, as of this writing, the agency had nearly 4000 "friends" and more than 150 related links on its page (
For example, one friend of the FDA page located outside the US asks on the agency's Facebook wall, why he can't send a carton of cigarettes to his friend in New Jersey for his birthday. Others have used the site to post negative comments about regulatory policies and initiatives.
The agency has online supporters, too. One friend comments that people would not be able to trust drugs, food, cosmetics, medical devices, and more if it weren't for FDA's activities. He writes, "I would love to see how this country would operate with no FDA and no regulations." Others use the page to ask questions about drug approvals or to lobby for their own pharma or healthcare causes.
To date, FDA does not seem to be responding to these comments or questions. Instead, the agency uses the page to make announcements about new initiatives, to post press releases, and so forth. FDA also has a more serious LinkedIn page and a Twitter account, the latter of which it has used to release recall alerts to the public rather quickly. Pharmaceutical Technology would like to hear your thoughts on FDA's use of social media tools and how you use them in your day-to-day work.
Angie Drakulich is the managing editor of Pharmaceutical Technology.
Articles in this issue
over 14 years ago
Pharmaceutical Technology, March 2011 Issue (PDF)over 14 years ago
Insider Solutions: Reporting Equipment Changesover 14 years ago
Next Steps for the US Biosimilar Regulatory Schemeover 14 years ago
Interphex on Tapover 14 years ago
In the Spotlight March 2011over 14 years ago
A First-Hand Look at India's Pharma Services Sectorover 14 years ago
Toward Expanding Understandingover 14 years ago
Report From Brazil March 2011Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





